An already record-setting summer heat wave will continue through August and will...
The FDA on Friday approved Zurzuvae, a rapid-acting medicine from Sage Therapeut...
The organization that runs ProMed, an early warning system on disease outbreaks,...
A new study emphasizes how, because of disruptions in care during the pandemic, ...
Mark Del Monte, CEO of the American Academy of Pediatrics, called the restrictio...
A new White House task force on drug shortages brainstormed policies for stemmin...
New York state recently passed a law reimbursing kidney donors. The federal gove...
Safety net hospitals are getting almost $1 billion less next year to offset the ...
Brain-computer interfaces hold promise for paralysis, but the business challenge...
Mesoblast plans follows an FDA response to the BLA resubmission for remestemcel-...
Evox and the Icahn School of Medicine will develop gene delivery vectors for car...
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently...
Cellectis provided updates for the three CAR-T cell therapies trials, with the t...
Gilead Sciences has posted net income of $1.03bn in Q2 of 2023 compared with $1....
Amid one of the worst dengue fever outbreaks in decades, Bangladesh has recorded...
BlueRock Therapeutics signed an agreement with bit.bio to discover and manufactu...
